Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). (Q33447721)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
scientific article

    Statements

    Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). (English)
    Julia Desheva
    Sergey Korovkin
    Alexander Mironov
    Andrey Rekstin
    Elena Grigorieva
    Alexandra Gambaryan
    Anton Katlinsky
    1 November 2008

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit